EMA Calls for Details, Narratives in Marketing Applications

Drug GMP Report
A A
Drugmakers need to provide adequate details — and include narratives — in describing manufacturing processes in their applications, but can leave out elements such as machinery serial numbers and general GMPs, according to the European Medicines Agency.

To View This Article:

Login

Subscribe To Drug GMP Report